Leptin-adjusted MBDA scores were investigated in a recent study [234], and it was demonstrated that they were associated with clinical disease activity and predicted radiographic progression of RA better than the original score and other markers of disease activity [234,235]. The gene discussed is LEP; the disease is rheumatoid arthritis.